FDA Inspection
Pfizer Health ABPfizer Health AB – FDA Inspection, Oct 13, 2017
Record Details
This FDA Inspection record concerns Pfizer Health AB, with an inspection on October 13, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- MRA McCulloughJ (Issuing Officer)
View Company Profile
ID · 4eaefdfc-38bc-4cea-9d8c-b001e14d6c66
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1098300
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Pfizer Health AB
6| Date | Classification | Office | Project area |
|---|---|---|---|
| January 20, 2025 | Not classified | Office of Inspections and Investigations | |
| May 13, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 31, 2017 | Not classified | Office of Inspections and Investigations | |
| March 17, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 6, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Pfizer Health AB
- FDA Inspection 1261991 - 2025-01-20
- FDA Inspection 1201247 - 2022-05-13
- FDA Inspection 1030979 - 2017-10-31
- FDA Inspection 1007911 - 2017-03-17
- FDA Inspection 799053 - 2012-09-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.